Lallemand Health Solutions’ probiotic production facilities receive GMP certification

d0500572-f626-4557-867c-910ff9d14fd0articleimage.jpg

08 Sep 2017 --- Lallemand Health Solutions in Canada is breaking new ground in probiotic production quality standards as both of its plants in Montreal and Mirabel have successfully passed the United States Pharmacopeia (USP) Quality Systems Good Manufacturing Practice (GMP) audit, becoming the first probiotic production facilities to receive this quality certificate.

“Such achievement illustrates our long-standing commitment to quality and demonstrates the level of our quality systems,” says Francine Mondou, President of Lallemand Health Solutions.

“For our customers, this helps provide them with assurance in the quality of our probiotic production operation. It also represents a stepping stone for those willing to get their finished product compliant with the USP verified program.”

“USP is the most authoritative source for dietary supplement GMP audits. USP’s GMP audit program serves dietary supplement and dietary ingredient manufacturers. It provides assurance that dietary supplement manufacturers not only meet FDA cGMPs but exceed them, as it is the only program that requires manufacturers to comply with both FDA and USP GMPs.”

USP GMPs include requirements of particular interest to retailers such as recall procedures, expiration dating supported by stability data for instance, explains John Atwater, Senior Director of Verification Services for USP.   

“This is the first time a probiotic production facility’s GMP quality systems have been verified by USP, and this can facilitate the task for the companies wanting to participate in USP verified program for their finished products, as more and more dietary supplement companies are interested in doing so”, he says.

Solange Henoud, Regulatory Affairs Director at Lallemand Health Solutions further commented: “In practice, this means that USP’s audit found that Lallemand’s quality system provided sufficient assurance that its two Canadian manufacturing sites met applicable FDA and USP GMP audit requirements. With the reputation of USP, we are confident that this will facilitate recognition by regulatory authorities beyond borders.”

RELATED ARTICLES
Homepicture

Algaia receives €4 million boost for seaweed extract production unit

22 May 2018 French biomarine company Algaia is to install a ...

Homepicture

Probiotics: Scientists investigate how seaweed can give a dietary boost to gut bacteria

11 May 2018 US researchers examining how to manipulate gut ...

Homepicture

Lonza: Positive start to 2018, driven by expanding healthcare businesses

04 May 2018 Lonza has reported a “positive” ...

Homepicture

Nexira enters strategic partnership for nutritionals, not giving up its acquisition plans

02 May 2018 Nexira, a global leader in natural and organic ...

Homepicture

Fermentalg reports on Q1 revenue as US expansion begins

20 Apr 2018 Fermentalg, a French supplier of microalgae for ...